Squadron Capital LLC sold 38,300 shares of OrthoPediatrics Corp (NASDAQ: KIDS) for approximately $943,302, disclosing the transactions in regulatory filings.
The sales occurred over three days, with weighted average prices ranging from $24.28 to $25.75 per share. On August 24, Squadron Capital sold 4,000 shares at an average of $25.75, followed by 16,300 shares at $24.74 on August 25, and 18,000 shares at $24.28 on August 26. Individual transaction prices fluctuated within narrow bands around these averages.
Squadron Capital, a 10% shareholder and director of OrthoPediatrics, stated the divestment was intended to provide additional capital for its other portfolio businesses. The firm retained 6,863,464 shares of OrthoPediatrics following the transactions.
OrthoPediatrics reported a 15% year-over-year increase in second-quarter revenue, totaling $70.5 million and exceeding Wall Street’s forecast of $68.22 million. Growth was driven by strong performance in trauma, deformity, and specialty bracing segments, offsetting a decline in scoliosis revenue. The company also raised its full-year revenue outlook.
Despite the revenue growth, OrthoPediatrics’ stock has declined 8.4% over the past week, though it remains up 35% year-to-date. Analysts at InvestingPro have flagged the stock as overvalued relative to its fair value estimate.
